Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MagCath is a medical device company focused on improving the safety and accuracy of catheter placement in neonatal and pediatric patients. The company's flagship technology is a magnetic guidance system designed to navigate peripherally inserted central catheters (PICCs) to the correct anatomical position without the use of ionizing radiation. This innovative approach aims to eliminate the reliance on X-ray fluoroscopy, thereby protecting vulnerable infants from the harmful effects of cumulative radiation exposure. By providing real-time, non-radiographic feedback, the MagCath system streamlines the bedside procedure and reduces the need for multiple repositioning attempts. Spun out of the University of Michigan, the company addresses a critical unmet need in the neonatal intensive care unit (NICU) environment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MagCath.